Cardiac ischemia and impairment of vascular endothelium function in hearts from GH-deficient rats: Protection by hexarelin
- 1 September 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 334 (2-3) , 201-207
- https://doi.org/10.1016/s0014-2999(97)01178-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Hexarelin Stimulation of Growth Hormone Release and mRNA Levels in an Infant and Adult Rat Model of Impaired GHRH FunctionNeuroendocrinology, 1997
- Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humansJournal of Clinical Endocrinology & Metabolism, 1996
- GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult ratsLife Sciences, 1994
- Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low dosesJournal of Clinical Endocrinology & Metabolism, 1993
- Nitric Oxide and Prostacyclin Influence Coronary Vasomotor Tone in Perfused Rabbit Heart and Modulate Endothelin-1 ActivityJournal of Cardiovascular Pharmacology, 1993
- A Nonpeptidyl Growth Hormone SecretagogueScience, 1993
- Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormoneEndocrinology, 1992
- Stimulation of Prostacyclin Synthesis by DefibrotideJournal of Cardiovascular Pharmacology, 1991
- GHRH Treatment: Studies in an Animal ModelActa Paediatrica, 1989
- Defibrotide, an Antithrombotic Substance That Preserves Postsynaptic α- and β-Adrenergic Function in Post Acute Infarcted Rabbit HeartsJournal of Cardiovascular Pharmacology, 1986